SIK2 and ovarian carcinoma: Given the synergistic effect of ARN-3261 and carboplatin in inhibiting the growth of cultured ovarian cancer cells, we investigated whether the addition of the SIK2 inhibitor could promote carboplatin response in xenograft models.